Pneumonia, Pneumococcal: Clinical Trials

11 trials for Pneumonia, Pneumococcal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 unknown, 1 terminated. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Completed 8, Unknown 2, Terminated 1

Follow Pneumonia, Pneumococcal: new trials by email Literature Review of Pneumonia, Pneumococcal trials Research Report on Pneumonia, Pneumococcal

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4
COVAX+PPV23;COVAX+IIV4, COVAX only (1st and 2nd dose), PPV23 for the 1st dose and IIV4 for the 2nd dose - Influenza, Human, Pneumonia, Pneumococcal
Phase 4UnknownChina National Biotec Group Company Limited14042021-05-062021-10-15
Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4
COVAX+IIV4; COVAX+PPV23, COVAX only (1st and 2nd dose), IIV4 for the 1st dose and PPV23 for the 2nd dose - Influenza, Human, Pneumonia, Pneumococcal
Phase 4CompletedChina National Biotec Group Company Limited11332021-03-102021-10-20
Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4
IIV4 and PPV23, IIV4, PPV23 - Influenza, Human, Pneumonia, Pneumococcal
Phase 4CompletedChina National Biotec Group Company Limited12242020-09-112022-08-02
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Vaccination with pneumococcal conjugate vaccine (PCV13), Standard Antibacterial Prophylaxis - Multiple Myeloma, Pneumococcal Infection
Phase 4CompletedMinsk Scientific-Practical Center for Surgery, Transplantation and Hematology362018-07-012022-08-31
Evaluation of PCV Schedules in a Naive Population in Vietnam
PCV 2p+1, PCV 3p+0, PCV 1p+1 - Pneumonia, Pneumococcal
Phase 4CompletedNagasaki University186522016-10-012024-04-19
The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine
Simultaneous administration of Pneumovax NP® and Fluvic HA syringe®, Sequential administration of Pneumovax NP® and Fluvic HA syringe® - Pneumococcal Pneumonia, Influenza
Phase 4CompletedKameda Medical Center1622015-11-012019-01-31
PCV10 Reactogenicity and Immunogenicity Study - Malindi
PCV10 and DTaP, hepatitis A vaccine, DTaP, PCV10 - Pneumococcal Pneumonia
Phase 4UnknownKEMRI-Wellcome Trust Collaborative Research Program6002010-01-012018-02-23
Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults
VACCINE: placebo, VACCINE: 13-valent pneumococcal conjugate vaccine - Pneumonia, Pneumococcal, Pneumococcal Infections
Phase 4CompletedPfizer844962008-09-012014-10-06
Targeting of Immune Response After Pneumococcal Vaccination
Pneumococcal polysaccharide vaccine, pneumococcal conjugate vaccine - Pneumococcal Pneumonia
Phase 4CompletedHelsinki University Central Hospital422005-01-012011-07-26
Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia
levofloxacin, ceftriaxone - Pneumonia, Pneumococcal
Phase 4TerminatedHospital Mutua de Terrassa452004-08-012007-02-01
Humoral Determinants of Immunity to Pneumococcal Infection
Prevnar, Pneumovax - Pneumonia, Pneumococcal Infections
Phase 4CompletedVA Office of Research and Development1142003-01-012017-09-05

Narrower conditions

Influenza, Human (4)  ·  Pneumococcal Infections (3)  ·  Pneumonia (2)  ·  COVID-19 (1)  ·  Febrile Neutropenia (1)  ·  Multiple Myeloma (1)

Broader conditions

Bacterial Infections (11)  ·  Bacterial Infections and Mycoses (11)  ·  Gram-Positive Bacterial Infections (11)  ·  Infections (11)  ·  Lung Diseases (11)  ·  Pneumonia, Bacterial (11)  ·  Respiratory Tract Diseases (11)  ·  Respiratory Tract Infections (11)  ·  Streptococcal Infections (11)  ·  Pneumonia (9)  ·  Pneumococcal Infections (8)  ·  Orthomyxoviridae Infections (4)  ·  RNA Virus Infections (4)  ·  Virus Diseases (4)  ·  Agranulocytosis (1)

Interventions

Pneumococcal Vaccines (3)  ·  Heptavalent Pneumococcal Conjugate Vaccine (2)  ·  PHiD-CV vaccine (2)  ·  10-valent pneumococcal conjugate vaccine (1)  ·  Ceftriaxone (1)  ·  Hepatitis A Vaccines (1)  ·  Levofloxacin (1)  ·  Vaccination (1)

Sponsors

China National Biotec Group Company Limited (3)  ·  Helsinki University Central Hospital (1)  ·  Hospital Mutua de Terrassa (1)  ·  KEMRI-Wellcome Trust Collaborative Research Program (1)  ·  Kameda Medical Center (1)  ·  Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology (1)  ·  Nagasaki University (1)  ·  Pfizer (1)  ·  VA Office of Research and Development (1)

Countries

China (3)  ·  Belarus (1)  ·  Finland (1)  ·  Japan (1)  ·  Kenya (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United States (1)  ·  Vietnam (1)

Top investigators

Anatoly Uss, MD/PhD (1)  ·  Anu Kantele, MD PhD (1)  ·  Daniel M Musher (1)  ·  Kei Nakashima, MD (1)  ·  Laura Hammitt, MD (1)  ·  Shanying Zhang (1)  ·  Xiaodong Sun (1)

Results publications

PMID 14998500, PMID 20686433, PMID 24086113, PMID 24465570, PMID 25785969, PMID 26083474, PMID 28173960, PMID 28410813, PMID 29017280, PMID 29429807, PMID 29561248, PMID 32418789, PMID 35931636, PMID 37780234, PMID 39602629, PMID 40396505, PMID 42202846